DRDanvic RosadiñoDIHSlidesetHIV10th APACC 2025DEBATE: Con Standpoint - Community Perspective - Danvic RosadiñoView Slideset
NKNagalingeswaran KumarasamyMD, FRCP, PhDSlidesetHIV10th APACC 2025DEBATE: Pro Standpoint - Clinical Perspective - Nagalingeswaran KumarasamyView Slideset
RKJTRayner Kay Jin TanPhDSlidesetHIV10th APACC 2025DEBATE: Con Standpoint - Clinical Perspective - Rayner Kay Jin TanView Slideset
SlidesetHIV10th APACC 2025Abstract #39 Data from the Positive Perspectives 3 Study Highlights the Continued Need for Expansion of Awareness, Belief and Confidence in Undetectable Equals Untransmittable (U=U) - Kota IwashashiView Slideset
SlidesetHIV10th APACC 2025Abstract #38 Building Inclusive Healthcare: Tackling HIV-Related Stigma and Discrimination in Malaysian Primary Care Clinics - Khalidah MaruanView Slideset
SlidesetHIV10th APACC 2025Abstract #37 Low Levels of Awareness of Undetectable=Untransmittable among MSM in Five Asian Countries: Results from the Asia Pacific MSM Internet Survey - Curtis ChanView Slideset
SlidesetHIV10th APACC 2025Abstract #36 Phase 3/3b Experience With Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes Beyond 124 Weeks in Participants Identifying as Asian - Jun Yong ChoiView Slideset
SlidesetHIV10th APACC 2025Abstract #35 Efficacy and Safety of Ainuovirine Plus Lamivudine, and Tenofovir DF in Young People with HIV-1: Pooled Analyses of RACER, and SPRINT Studies - Two Randomized, Active-Controlled Phase 3 Trials -Fujie ZhangView Slideset
SlidesetHIV10th APACC 2025Abstract #34 Week 96 Results from Dolutegravir/ Lamivudine Versus Bictegravir/ Emtricitabine/Tenofovir Alafenamide Fumarate: Real-World Assessment of Weight Gain in People Living with HIV of Asian OrigiN (DRAGON) - Chien-Yu ChengView Slideset
SlidesetHIV10th APACC 2025Abstract #33 Twelve-Month (12M) Effectiveness and Safety of Bictegravir/Emtricitabine/ Tenofovir Alafenamide (B/F/TAF) in Treatment-Experienced People with HIV: A Pooled Analysis from Observational Cohort Studies Across Asia - Rumi MinamiView Slideset
SlidesetHIV10th APACC 2025Abstract #32 Informing the Design of Future PrEP Strategies for MSM in Taiwan: A Bayesian Discrete Choice Experiment Analysis - Joyce Huei-Jiuan WuView Slideset
